Elicera Therapeutics AB (SE0015382080) — research page
SE · se-cm-kg/SSME/SE0015382080 · as of 2026-11-06
Identity and listing
The issuer is Elicera Therapeutics AB, listed on First North Sweden under ticker SE0015382080, with ISIN SE0015382080 and LEI 549300I35L0R4INBFG27. Its security type, segment, sector and jurisdiction are not on the record. Its listing status is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | Elicera Therapeutics AB | source · 2026-11-06 |
| exchange | First North Sweden | source · 2026-11-06 |
| ticker | SE0015382080 | source · 2026-11-06 |
| ISIN | SE0015382080 | source · 2026-11-06 |
| LEI | 549300I35L0R4INBFG27 | source · 2026-11-09 |
| security type | not on the record | |
| segment | not on the record | |
| sector | not on the record | |
| jurisdiction | not on the record | |
| status | listed, not halted | source · 2026-11-09 |
The disclosure read
The record holds 74 filings in the twelve months to 2026-11-06, across 37 filing days. The median gap between filing days is 7.0 days. The latest filing is dated 2026-11-05 and is of type Investor News, 1 day before the record date. The exchange median is 11.0 days of cadence gap, 21 filings and 7 days of latency across 325 issuers on First North Sweden. The sector median is not on the record.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 74 | 7 | 1 |
| exchange median: First North Sweden (325 issuers) | 21 | 11 | 7 |
| date | type | category | filing |
|---|---|---|---|
| 2026-11-05 | Investor News | Investor News | Elicera Therapeutics får patentgodkännande för ELC-401 i Kina |
| 2026-11-05 | Investor News | Investor News | Elicera Therapeutics receives notice of allowance for ELC-401 patent in China |
| 2026-10-30 | Investor News | Investor News | Elicera Therapeutics medgrundare får anslag på totalt 4 MSEK från Vetenskapsrådet för forskning om CAR-T-celler mot solida tumörer |
| 2026-10-30 | Investor News | Investor News | Elicera Therapeutics co-founder receives grant totaling SEK 4 million from the Swedish Research Council for research on CAR-T cells against solid tumors |
| 2026-10-12 | Company Announcement | Company Announcement | Elicera Therapeutics completes Phase I part of CARMA study of ELC-301 and reports complete metabolic response in 8 of 12 patients |
window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor and its location are not on the record. The market's record does not carry auditor changes for this register.
Events and halts
The record does not carry listing, delisting, name change, domicile change or segment move events for this register. The issuer is listed, not halted.
Orderability
The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/se/mifid-ii-product-governance/r1, and the chapter is as of 2026-11-04.
rule acm-68000/se/mifid-ii-product-governance/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
No research houses were found on the issuer's investor-relations pages read.
Open research
No openly published research notes were found on the record.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The vintage for this market is not sealed. No issuer years are sealed, and the market's earliest sealed date and the live record start date are not on the record.
Sources
6 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://firds.esma.europa.eu/firds/ (identity.exchange)
- 10.2
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- 10.3
- https://mcp.se-cm-kg.ai/events/SSME/SE0015382080 (the disclosure lines)
- 10.4
- https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation (the halt flag)
- 10.5
- https://se.eu-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.6
- https://mcp.se-cm-kg.ai/record/SSME/SE0015382080 (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"SE0015382080"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:0f664e17e21afe45.